Azelaic acid 5 mg / cupric oxide 1.5 mg / folic acid 0.5 mg / niacinamide 600 mg / pyridoxine 5 mg / zinc oxide 10 mg Oral Tablet [NicAzel]
RxNorm 1145114

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1145114 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: azelaic acid 5 mg / cupric oxide 1.5 mg / folic acid 0.5 mg / niacinamide 600 mg / pyridoxine 5 mg / zinc oxide 10 mg Oral Tablet [NicAzel].

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Azelaic acid 5 mg / Cupric oxide 1.5 mg / folate 0.5 mg / Niacinamide 600 mg / vit-B6 5 mg / ZNO 10 mg Oral Tablet [NicAzel]
AUI:3856147
SY
Azelaic acid 5 mg / Cupric oxide 1.5 mg / folate 0.5 mg / Niacinamide 600 mg / vitamin B6 5 mg / ZNO 10 mg Oral Tablet [NicAzel]
AUI:3867960
SBD
Azelaic acid 5 mg / cupric oxide 1.5 mg / folic acid 0.5 mg / niacinamide 600 mg / pyridoxine 5 mg / zinc oxide 10 mg Oral Tablet [NicAzel]
AUI:12359702
SY
NicAzel (azelaic acid 5 mg / cupric oxide 1.5 mg / folic acid 0.5 mg / vitamin B3 600 mg / vitamin B6 5 mg / zinc oxide 10 mg) Oral Tablet
AUI:3801029

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SYPrescribable

Synonym (SY):
Azelaic acid 5 mg / Cupric oxide 1.5 mg / folate 0.5 mg / Niacinamide 600 mg / vit-B6 5 mg / ZNO 10 mg Oral Tablet [NicAzel]
(Atom ID: 3856147)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
azelaic acid 5 MG / Cupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 600 MG / vit-B6 5 MG / ZNO 10 MG Oral Tablet [NicAzel]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1145114
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3856147
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1145114
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SYPrescribable

Synonym (SY):
Azelaic acid 5 mg / Cupric oxide 1.5 mg / folate 0.5 mg / Niacinamide 600 mg / vitamin B6 5 mg / ZNO 10 mg Oral Tablet [NicAzel]
(Atom ID: 3867960)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
azelaic acid 5 MG / Cupric oxide 1.5 MG / folate 0.5 MG / Niacinamide 600 MG / vitamin B6 5 MG / ZNO 10 MG Oral Tablet [NicAzel]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1145114
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3867960
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1145114
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SBDPrescribable

Semantic Branded Drug (SBD):
Azelaic acid 5 mg / cupric oxide 1.5 mg / folic acid 0.5 mg / niacinamide 600 mg / pyridoxine 5 mg / zinc oxide 10 mg Oral Tablet [NicAzel]
(Atom ID: 12359702)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / niacinamide 600 MG / pyridoxine 5 MG / zinc oxide 10 MG Oral Tablet [NicAzel]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1145114
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12359702
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1145114
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1145104} 18602
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1145105} 21837
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1145106} 7405
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1145107} 11423
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{317635} 4511
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{802689} 684879
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1145104} 18602
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1145105} 1427198
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1145106} 7405
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1145107} 1546264
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{317635} 4511
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{802689} 684879
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AVAILABLE STRENGTH
5 MG (expressed as azelaic acid) / 1.5 MG / 0.5 MG / 600 MG / 5 MG / 10 MG
Available drug strengths listed in the order of ingredients from the drug
RXN BOSS FROM
{1145104} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1145105} AM
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1145106} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1145107} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{317635} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{802689} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN HUMAN DRUG
US
Drug available for use in Humans
RXTERM FORM
Tab
The RxTerm dose form name for this drug

SYPrescribable

Synonym (SY):
NicAzel (azelaic acid 5 mg / cupric oxide 1.5 mg / folic acid 0.5 mg / vitamin B3 600 mg / vitamin B6 5 mg / zinc oxide 10 mg) Oral Tablet
(Atom ID: 3801029)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
NicAzel (azelaic acid 5 MG / cupric oxide 1.5 MG / folic acid 0.5 MG / vitamin B3 600 MG / vitamin B6 5 MG / zinc oxide 10 MG) Oral Tablet
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1145114
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3801029
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1145114
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Folate



[Learn More]


* Please review the disclaimer below.